Literature DB >> 22237821

Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension.

Alexandra J Sinclair1, Michael A Burdon, Peter G Nightingale, Timothy D Matthews, Andrew Jacks, Mark Lawden, Arul Sivaguru, Brent J Gaskin, Saaeha Rauz, Carl E Clarke, Alexandra K Ball.   

Abstract

The appearance of the optic disc is a key measure of disease status in idiopathic intracranial hypertension (IIH). The Frisén classification describes stages of optic disc swelling (grades 0-5). It is the only classification of papilloedema, and is used internationally in clinical and research practice. Despite this, there has been very limited evaluation of the scale. We assessed the inter-rater reproducibility and ability to discriminate optic disc changes over time using the Frisén classification compared with a system of ranking papilloedema severity in patients with IIH. Paired disc photographs (before and after treatment) were obtained from 47 patients with IIH (25 acute and 22 chronic). Six neuro-ophthalmologists blinded to patient identity, clinical information and chronology of the photographs reviewed the discs and allocated a Frisén grade and ranked the paired discs in order of papilloedema severity (disc ranking). A total of 188 optic disc photographs were reviewed. All six reviewers agreed in only three comparisons (1.6%) when using the Frisén classification, compared with 42 comparisons (45.2%) when using disc ranking. The probability of agreement between any two reviewers was 36.1% for Frisén grade and 70.0% for disc ranking. Disc ranking had significantly greater sensitivity for finding differences in degree of disc oedema, identifying a difference in 75.3% of paired photographs compared to 53.2% detected using the Frisén classification (p < 0.001). This study demonstrated the limited reproducibility and discriminative ability of the Frisén classification in identifying changes in serial optic disc photographs in IIH. Simple optic disc ranking appears to be a more sensitive and reliable tool to monitor changes in optic disc appearance. The use of disc ranking in clinical practice and research studies is recommended to monitor alterations in optic disc appearance until alternative schemes, specific to IIH, have been developed.

Entities:  

Mesh:

Year:  2012        PMID: 22237821     DOI: 10.1007/s00415-011-6365-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

Review 1.  Idiopathic intracranial hypertension.

Authors:  Alex K Ball; Carl E Clarke
Journal:  Lancet Neurol       Date:  2006-05       Impact factor: 44.182

2.  Effects of weight loss on the course of idiopathic intracranial hypertension in women.

Authors:  M J Kupersmith; L Gamell; R Turbin; V Peck; P Spiegel; M Wall
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

3.  Swelling of the optic nerve head: a staging scheme.

Authors:  L Frisén
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

4.  Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.

Authors:  V A Shah; R H Kardon; A G Lee; J J Corbett; M Wall
Journal:  Neurology       Date:  2008-02-19       Impact factor: 9.910

5.  Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study.

Authors:  Alexandra J Sinclair; Michael A Burdon; Peter G Nightingale; Alexandra K Ball; Peter Good; Timothy D Matthews; Andrew Jacks; Mark Lawden; Carl E Clarke; Paul M Stewart; Elizabeth A Walker; Jeremy W Tomlinson; Saaeha Rauz
Journal:  BMJ       Date:  2010-07-07

6.  Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.

Authors:  N Celebisoy; F Gökçay; H Sirin; O Akyürekli
Journal:  Acta Neurol Scand       Date:  2007-11       Impact factor: 3.209

7.  The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)

Authors:  L N Johnson; G B Krohel; R W Madsen; G A March
Journal:  Ophthalmology       Date:  1998-12       Impact factor: 12.079

8.  Idiopathic intracranial hypertension in men.

Authors:  B B Bruce; S Kedar; G P Van Stavern; D Monaghan; M D Acierno; R A Braswell; P Preechawat; J J Corbett; N J Newman; V Biousse
Journal:  Neurology       Date:  2008-10-15       Impact factor: 9.910

9.  Idiopathic intracranial hypertension. A prospective study of 50 patients.

Authors:  M Wall; D George
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

10.  A randomised controlled trial of treatment for idiopathic intracranial hypertension.

Authors:  Alexandra K Ball; Andrew Howman; Keith Wheatley; Michael A Burdon; Timothy Matthews; Andrew S Jacks; Mark Lawden; Arul Sivaguru; Alexandra Furmston; Steven Howell; Basil Sharrack; M Brendan Davies; Alexandra J Sinclair; Carl E Clarke
Journal:  J Neurol       Date:  2010-12-16       Impact factor: 4.849

  10 in total
  19 in total

1.  Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

Authors:  Peggy Auinger; Mary Durbin; Steven Feldon; Mona Garvin; Randy Kardon; John Keltner; Mark Kupersmith; Patrick Sibony; Kim Plumb; Jui-Kai Wang; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-04       Impact factor: 4.799

2.  Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.

Authors:  William S Fischer; Michael Wall; Michael P McDermott; Mark J Kupersmith; Steven E Feldon
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 3.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

4.  Ocular ultrasound for monitoring pseudotumor cerebri syndrome.

Authors:  Piergiorgio Lochner; Klaus Fassbender; Martin Lesmeister; Raffaele Nardone; Andrea Orioli; Francesco Brigo; Erwin Stolz
Journal:  J Neurol       Date:  2017-12-14       Impact factor: 4.849

5.  Optical coherence tomography use in idiopathic intracranial hypertension.

Authors:  Kiran Malhotra; Tanyatuth Padungkiatsagul; Heather E Moss
Journal:  Ann Eye Sci       Date:  2020-03-15

6.  Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.

Authors: 
Journal:  Ophthalmology       Date:  2015-07-18       Impact factor: 12.079

7.  The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.

Authors:  Catherine R Sheils; William S Fischer; Rachel A Hollar; Lisa M Blanchard; Steven E Feldon
Journal:  Am J Ophthalmol       Date:  2018-08-04       Impact factor: 5.258

8.  Early Loss of Optic Cup with Increased Intracranial Pressure.

Authors:  John Horsburgh; Rustom Bativala; Michael Burdon; Peter Shah
Journal:  Neuroophthalmology       Date:  2018-01-09

Review 9.  Perspectives on diagnosis and management of adult idiopathic intracranial hypertension.

Authors:  Irini Chatziralli; Panagiotis Theodossiadis; George Theodossiadis; Ioannis Asproudis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-04       Impact factor: 3.117

Review 10.  Optical coherence tomography (OCT) in neuro-ophthalmology.

Authors:  Neda Minakaran; Emanuel R de Carvalho; Axel Petzold; Sui H Wong
Journal:  Eye (Lond)       Date:  2020-11-25       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.